1 / 6

Biomarker Market Size, Industry Trends, Share and Forecast 2018-2023

The key factors contributing to the growth of the global biomarker market include high prevalence of chronic diseases, rising adoption of biomarker for diagnostic applications, high government funding for cancer research and clinical trials, increasing application in drug discovery and development.

mansi3210
Download Presentation

Biomarker Market Size, Industry Trends, Share and Forecast 2018-2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Biomarker Market, Size, Share, Analysis Report & Forecast to 2025 Request a Free Sample of our Biomarker Market: https://www.omrglobal.com/request- sample/global-biomarker-market Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

  2. The global metabolomics biomarker market size was accounted at $188 million in 2018 and estimated to grow at a CAGR of 12.2% during the forecast period. The global metabolomics biomarker is growing at a significant rate owing to various factors such as ongoing research on metabolomics biomarker, innovative development in informatics and analytical technologies, and extensive applications such as in the detection of colorectal cancer. The increasing prevalence of colorectal cancer across the globe is one of the major factors for the wide adoption of metabolomics biomarkers for early detection of disease. According to the American Cancer Society, in 2019, the number of new colon cancer cases is estimated to be around 101,420 and the number of new rectal cancer is estimated to be nearly 44,180 in the US. The metabolomics is increasingly being adopted in the development of precision medicines for various chronic diseases such as cancer and CVD. This, in turn, is driving the growth of the global metabolomics biomarker market. A full Report of Biomarker Market is Available at: https://www.omrglobal.com/industry- reports/global-biomarker-market Global metabolomics biomarker market has been segmented on the basis of technology, application, end-user, and regions. On the basis of technology, the market has been segregated into chromatography, mass spectrometry, nuclear magnetic resonance (NMR), and others. The chromatography segment is further sub-segmented into gas chromatography (GC), high-performance liquid chromatography (HPLC), and ultra-performance liquid chromatography (UPLC). Mass- spectrometry combined with chromatography technology is dominating the market share with around 65% contribution to the overall market in 2017. Mass spectrometry along with chromatography analyzes a wide range of metabolites of varying molecular weight; thereby, finds greater adoption across various end-user. Moreover, the combination has a high peak capacity to cover a wide range of concentrations and detect both hydrophobic and hydrophilic compounds, which supports their adoption in metabolomics in the various end-use application. Request a Free Sample of our Biomarker Market: https://www.omrglobal.com/request- sample/global-biomarker-market The key players operating in the global metabolomics biomarker market include BG Medicine, Inc., Biomark Diagnostics Inc., Evotec A.G., Merck KGaA, Metabolomic Diagnostics Ltd., Stemina Biomarker Discovery, Inc., and Thermo Fisher Scientific, Inc., among others. The companies are developing innovative metabolomics biomarker in the market, in order to develop effective diagnostic and treatment for infectious and metabolic diseases. Furthermore, the market players are adopting various strategies, in order to sustain in the highly competitive market, which includes merger & acquisition, geographical expansion, joint ventures, and product development, among others. Global Metabolomics Biomarker Market - Segmentation By Application • • • • • Toxicological Studies Drug Testing Cancer Cardiovascular Disorders Neurological Disorders

  3. • • Inborn Errors of Metabolism Other By Technologies • • • • • • • • Gas Chromatography (GC) High-Performance Liquid Chromatography (HPLC) Ultra-Performance Liquid Chromatography (UPLC) Nuclear Magnetic Resonance (NMR) Mass Spectrometry Surface-Based Mass Analysis Bioinformatics Other By End Users • • • Hospitals Diagnostic Labs Research Centres Global Metabolomics Biomarker Market – Segment by Region North America • • US Canada Europe • • • • • • Germany UK France Spain Italy Rest of Europe Asia-Pacific • • • • China India Japan Rest of Asia-Pacific Rest of the World COMPANY PROFILES

  4. •ABBOTT LABORATORIES INC. •ACS BIOMARKER •AGILENT TECHNOLOGIES •ABCODIA LTD. •ADX NEUROSCIENCES NV •AVACTA GROUP PLC •AGENDIA •ASTELLAS PHARMA INC. •ANGLE BIOSCIENCES INC. •ALMAC GROUP •ALCEDIAG •BANYAN BIOMARKERS INC. •BCAL DIAGNOSTICS •BG MEDICINE INC. •BECKMAN COULTER, INC. •BECTON, DICKINSON AND COMPANY •BIOCLINICA •BIODESIX, INC. •BIOMÉRIEUX SA •BIO-RAD LABORATORIES INC. •BIOMARKER PHARMACEUTICALS CO., LTD •BIOMARKERBAY B. V. •BIOMARK DIAGNOSTICS INC. •BIOAGILYTIX LABS LLC •BIOMARKER LABS, INC. •BIOGAZELLE NV •BIOFLUIDICA INC. •BIOTHERA PHARMACEUTICALS INC. •CELLOMATICS BIOSCIENCES LTD. •CELERION •CISBIO BIOASSAYS •COVANCE INC. •CRITICAL DIAGNOSTICS •CROSSBETA BIOSCIENCE B.V. •CAMBRIDGE BIOMEDICAL INC. •CHARLES RIVER LABORATORIES, INC., •DIAGENIC ASA •DENOVO BIOPHARMA LLC •DRUMETIX LABORATORIES, LLC •ENZO BIOCHEM INC.

  5. •EXTERNAUTICS SPA •F. HOFFMANN-LA ROCHE LTD •FRONTAGE LABS •FUTURE DIAGNOSTICS SOLUTIONS B.V. •GENENEWS LTD •GLYCOTECHNICA LTD. •HEALTHSPAN DIAGNOSTICS LLC •HOLOGIC INC. •HUMAN LONGEVITY, INC. •HVIVO SERVICES LIMITED •INSIGHT GENETICS INC. •ILLUMINA, INC. •ICON PLC •JANSSEN GLOBAL SERVICES, •LLCKCAS – BIOANALYTICAL & BIOMARKER SERVICES •LUMINEX CORPORATION •LIPOTYPE GMBH •MAPA BIOANALYSIS •MD BIOSCIENCES •MDNA LIFE SCIENCES INC. •MDXHEALTH •MERCK & CO., INC. •METABOLON INC. •METANOMICS HEALTH GMBH •MYRIAD GENETICS INC. •NEOGENOMICS, INC. •NANOSOMIX INC. •NANOSTRING TECHNOLOGIES, INC. •NOVARTIS AG •NORDIC BIOSCIENCE •PFIZER INC. •PERKINELMER INC. •PAMGENE INTERNATIONAL B.V. •PACIFIC BIOMARKERS INC. •PERSONALIS INC •PRECISION MEDICINE GROUP, INC. •PRECISION BIOMARKER RESOURCES INC. •QIAGEN N.V •QUANTERIX CORPORATION •Q2 SOLUTIONS

  6. •QUIBIM SL •RANDOX LABORATORIES LTD. •RESPONSE BIOMEDICAL CORPORATION •SIEMENS HEALTHINEERS •SIGNOSIS INC. •SIMPLICITYBIO SA •SGS SA •SYNEXA LIFE SCIENCES •STEMINA BIOMARKER DISCOVERY, INC. •THERMO FISHER SCIENTIFIC CORPORATION •TWAN BIOTECH COMPANY •TAMIRNA GMBH •VALIRX PLC For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/global-biomarker-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803040404

More Related